Rentokil Initial Valuation

RKLIF Stock  USD 4.69  0.67  16.67%   
At this time, the company appears to be fairly valued. Rentokil Initial plc holds a recent Real Value of $4.65 per share. The prevailing price of the company is $4.69. Our model determines the value of Rentokil Initial plc from analyzing the company fundamentals such as Shares Outstanding of 2.52 B, return on equity of 0.21, and Operating Margin of 0.13 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
4.69
Please note that Rentokil Initial's price fluctuation is moderately volatile at this time. Calculation of the real value of Rentokil Initial plc is based on 3 months time horizon. Increasing Rentokil Initial's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Rentokil pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Rentokil Initial plc. Since Rentokil Initial is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Rentokil Pink Sheet. However, Rentokil Initial's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.69 Real  4.65 Hype  4.69 Naive  4.69
The real value of Rentokil Pink Sheet, also known as its intrinsic value, is the underlying worth of Rentokil Initial plc Company, which is reflected in its stock price. It is based on Rentokil Initial's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Rentokil Initial's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
4.65
Real Value
8.11
Upside
Estimating the potential upside or downside of Rentokil Initial plc helps investors to forecast how Rentokil pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rentokil Initial more accurately as focusing exclusively on Rentokil Initial's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.944.434.92
Details
Hype
Prediction
LowEstimatedHigh
1.234.698.15
Details
Naive
Forecast
LowNext ValueHigh
1.234.698.15
Details

Rentokil Initial Total Value Analysis

Rentokil Initial plc is at this time forecasted to have takeover price of 18.1 B with market capitalization of 15.32 B, debt of 1.26 B, and cash on hands of 2.37 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Rentokil Initial fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
18.1 B
15.32 B
1.26 B
2.37 B

Rentokil Initial Investor Information

About 76.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.21. Rentokil Initial plc last dividend was issued on the 4th of August 2022. Rentokil Initial plc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Rentokil Initial Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Rentokil Initial has an asset utilization ratio of 68.39 percent. This implies that the Company is making $0.68 for each dollar of assets. An increasing asset utilization means that Rentokil Initial plc is more efficient with each dollar of assets it utilizes for everyday operations.

Rentokil Initial Ownership Allocation

Rentokil Initial owns a total of 2.52 Billion outstanding shares. The majority of Rentokil Initial plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rentokil Initial plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rentokil Initial. Please pay attention to any change in the institutional holdings of Rentokil Initial plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Rentokil Initial Profitability Analysis

The company reported the revenue of 2.96 B. Net Income was 263.2 M with profit before overhead, payroll, taxes, and interest of 2.37 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Rentokil Initial's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Rentokil Initial and how it compares across the competition.

About Rentokil Initial Valuation

The pink sheet valuation mechanism determines Rentokil Initial's current worth on a weekly basis. Our valuation model uses a comparative analysis of Rentokil Initial. We calculate exposure to Rentokil Initial's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Rentokil Initial's related companies.
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom. Rentokil Initial operates under Specialty Business Services classification in the United States and is traded on OTC Exchange. It employs 46000 people.

8 Steps to conduct Rentokil Initial's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Rentokil Initial's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Rentokil Initial's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Rentokil Initial's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Rentokil Initial's revenue streams: Identify Rentokil Initial's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Rentokil Initial's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Rentokil Initial's growth potential: Evaluate Rentokil Initial's management, business model, and growth potential.
  • Determine Rentokil Initial's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Rentokil Initial's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Rentokil Initial Growth Indicators

Investing in growth stocks can be very risky. If the company such as Rentokil Initial does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding1.9 B
Quarterly Earnings Growth Y O Y0.041
Forward Price Earnings21.8818
Retained Earnings3.2 B

Complementary Tools for Rentokil Pink Sheet analysis

When running Rentokil Initial's price analysis, check to measure Rentokil Initial's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rentokil Initial is operating at the current time. Most of Rentokil Initial's value examination focuses on studying past and present price action to predict the probability of Rentokil Initial's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rentokil Initial's price. Additionally, you may evaluate how the addition of Rentokil Initial to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stocks Directory
Find actively traded stocks across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk